[Delayed wound healing during therapy of cutaneous graft-versus-host disease with everolimus]. / Wundheilungsstörung bei kutaner Graft-versus-Host-Disease unter Therapie mit Everolimus.

Graft-versus-host-disease (GvHD) is despite improvement in transplantation medicine the major cause for morbidity and mortality after allogeneic stem cell transplantation. We describe a patient with chronic cutaneous GvHD who developed massive skin ulcerations after changing the immunosuppressive therapy to a mammalian target of rapamycin (mTOR)-inhibitor.